Optic Nerve Disorders Drug Development Pipeline Remains Influenced by Increasing Prevalence of LOHN and Glaucoma
Several drugs are in pipeline for the treatment of disorders associated with vision loss such as optic neuropathy, glaucoma, LHON, and optic neuritis. Nearly 10 products are under development for optic neuropathy, 13 drugs for glaucoma and over 16 drugs for LHON disease. These insights are according to the report titled "Optic Nerve Disorders Drug Development Pipeline Review, 2018," which has been recently added to the repository of Market Research Hub (MRH).
View full press release